What were your “Top 3” Presentations/Studies from the meeting this year? How will it impact your clinical practice?
New comment by Radiation Oncologist at SSM Cancer Center/St Louis CyberKnife ( September 10, 2024)
Unfortunately, the TrilynX study was closed after interim analysis showed it was unlikely to meet its primary objective of prolonging event-free survival.